Performance of ENOV Enovis | -17.9% in 12m
Compare ENOV with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Enovis with its related Sector/Index XLV
Performance Duell ENOV vs XLV
| TimeFrame | ENOV | XLV |
|---|---|---|
| 1 Week | 2.58% | 0.70% |
| 1 Month | -6.26% | -2.43% |
| 3 Months | -11.0% | 3.84% |
| 6 Months | -29.9% | 11.10% |
| 12 Months | -17.9% | 19.58% |
| YTD | -28.2% | 11.38% |
| Rel. Perf. 1m | -0.57 | |
| Rel. Perf. 3m | -2.91 | |
| Rel. Perf. 6m | -4.70 | |
| Rel. Perf. 12m | -3.35 | |
| Spearman 1m | -0.86 | -0.540 |
| Spearman 3m | -0.71 | 0.537 |
Is Enovis a good stock to buy?
No, based on ValueRay Fundamental Analyses, Enovis (NYSE:ENOV) is currently (October 2024)
a stock to sell. It has a ValueRay Fundamental Rating of -53.12 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ENOV as of October 2024 is 35.11. This means that ENOV is currently overvalued and has a potential downside of -11.85% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ENOV as of October 2024 is 35.11. This means that ENOV is currently overvalued and has a potential downside of -11.85% (Sold with Premium).
Is ENOV a buy, sell or hold?
- Strong Buy: 7
- Buy: 2
- Hold: 1
- Sell: 0
- Strong Sell: 0
Values above 0%: ENOV is performing better - Values below 0%: ENOV is underperforming
Compare ENOV with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 1.43% | -9.59% | -45.55% | -54.45% |
| US NASDAQ 100 | QQQ | 2.26% | -10.13% | -44.10% | -53.87% |
| US Dow Jones Industrial 30 | DIA | 0.98% | -9.00% | -44.17% | -47.15% |
| German DAX 40 | DBXD | 0.34% | -10.88% | -37.64% | -48.30% |
| UK FTSE 100 | ISFU | 1.70% | -5.31% | -40.80% | -42.04% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 14.43% | -25.06% | -40.73% | -27.90% |
| Hongkong Hang Seng | HSI | 7.22% | -17.72% | -52.14% | -27.52% |
| Japan Nikkei 225 | EXX7 | 2.68% | -10.58% | -31.08% | -41.12% |
| India NIFTY 50 | INDA | 2.72% | -4.32% | -41.09% | -46.76% |
| Brasil Bovespa | EWZ | 4.55% | -0.93% | -25.11% | -18.75% |
ENOV Enovis vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 1.92% | -10.30% | -43.92% | -54.81% |
| Consumer Discretionary | XLY | 2.13% | -9.45% | -43.98% | -44.03% |
| Consumer Staples | XLP | 0.82% | -4.68% | -44.22% | -42.52% |
| Energy | XLE | 4.00% | -10.82% | -25.71% | -18.85% |
| Financial | XLF | -0.84% | -10.65% | -48.45% | -61.70% |
| Health Care | XLV | 1.88% | -3.83% | -40.99% | -37.44% |
| Industrial | XLI | 0.59% | -11.89% | -43.89% | -57.24% |
| Materials | XLB | 0.58% | -9.70% | -38.54% | -45.28% |
| Real Estate | XLRE | 0.39% | -4.56% | -52.99% | -53.66% |
| Technology | XLK | 2.25% | -10.58% | -43.77% | -55.22% |
| Utilities | XLU | 1.16% | -8.81% | -58.50% | -58.44% |
| Aerospace & Defense | XAR | 1.37% | -11.42% | -51.10% | -55.48% |
| Biotech | XBI | 0.30% | -4.33% | -45.06% | -63.08% |
| Homebuilder | XHB | 1.15% | -9.14% | -50.52% | -88.64% |
| Retail | XRT | 0.53% | -8.54% | -39.50% | -47.14% |
Does Enovis outperform its market, is ENOV a Sector Leader?
No, over the last 12 months Enovis (ENOV) made -17.86%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 19.58%.
Over the last 3 months ENOV made -10.97%, while XLV made 3.84%.
No, over the last 12 months Enovis (ENOV) made -17.86%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 19.58%.
Over the last 3 months ENOV made -10.97%, while XLV made 3.84%.
| Period | ENOV | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -6.26% | -2.43% | 3.33% |
| 3 Months | -10.97% | 3.84% | 3.57% |
| 12 Months | -17.86% | 19.58% | 36.59% |